111 related articles for article (PubMed ID: 27262438)
1. MiR-485 inhibits metastasis and EMT of lung adenocarcinoma by targeting Flot2.
Mou X; Liu S
Biochem Biophys Res Commun; 2016 Sep; 477(4):521-526. PubMed ID: 27262438
[TBL] [Abstract][Full Text] [Related]
2. miR-133 involves in lung adenocarcinoma cell metastasis by targeting FLOT2.
Wei G; Xu Y; Peng T; Yan J
Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):224-230. PubMed ID: 28503944
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-33b inhibits lung adenocarcinoma cell growth, invasion, and epithelial-mesenchymal transition by suppressing Wnt/β-catenin/ZEB1 signaling.
Qu J; Li M; An J; Zhao B; Zhong W; Gu Q; Cao L; Yang H; Hu C
Int J Oncol; 2015 Dec; 47(6):2141-52. PubMed ID: 26459797
[TBL] [Abstract][Full Text] [Related]
4. microRNA-802 inhibits epithelial-mesenchymal transition through targeting flotillin-2 in human prostate cancer.
Wang D; Lu G; Shao Y; Xu D
Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28188157
[TBL] [Abstract][Full Text] [Related]
5. miR-449a targets Flot2 and inhibits gastric cancer invasion by inhibiting TGF-β-mediated EMT.
Li Q; Peng J; Li X; Leng A; Liu T
Diagn Pathol; 2015 Nov; 10():202. PubMed ID: 26576674
[TBL] [Abstract][Full Text] [Related]
6. microRNA-214 promotes epithelial-mesenchymal transition and metastasis in lung adenocarcinoma by targeting the suppressor-of-fused protein (Sufu).
Long H; Wang Z; Chen J; Xiang T; Li Q; Diao X; Zhu B
Oncotarget; 2015 Nov; 6(36):38705-18. PubMed ID: 26462018
[TBL] [Abstract][Full Text] [Related]
7. TWIST1 upregulates miR-214 to promote epithelial-to-mesenchymal transition and metastasis in lung adenocarcinoma.
Liu C; Luo J; Zhao YT; Wang ZY; Zhou J; Huang S; Huang JN; Long HX; Zhu B
Int J Mol Med; 2018 Jul; 42(1):461-470. PubMed ID: 29693173
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-485-5p suppresses the proliferation, migration and invasion of small cell lung cancer cells by targeting flotillin-2.
Gao F; Wu H; Wang R; Guo Y; Zhang Z; Wang T; Zhang G; Liu C; Liu J
Bioengineered; 2019 Dec; 10(1):1-12. PubMed ID: 30836864
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-181a regulates epithelial-mesenchymal transition by targeting PTEN in drug-resistant lung adenocarcinoma cells.
Li H; Zhang P; Sun X; Sun Y; Shi C; Liu H; Liu X
Int J Oncol; 2015 Oct; 47(4):1379-92. PubMed ID: 26323677
[TBL] [Abstract][Full Text] [Related]
10. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z
Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096
[TBL] [Abstract][Full Text] [Related]
11. Identification of FLOT2 as a novel target for microRNA-34a in melanoma.
Liu R; Xie H; Luo C; Chen Z; Zhou X; Xia K; Chen X; Zhou M; Cao P; Cao K; Zhou J
J Cancer Res Clin Oncol; 2015 Jun; 141(6):993-1006. PubMed ID: 25403318
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-200c inhibits epithelial-mesenchymal transition, invasion, and migration of lung cancer by targeting HMGB1.
Liu PL; Liu WL; Chang JM; Chen YH; Liu YP; Kuo HF; Hsieh CC; Ding YS; Chen WW; Chong IW
PLoS One; 2017; 12(7):e0180844. PubMed ID: 28727734
[TBL] [Abstract][Full Text] [Related]
13. miR-483-5p promotes invasion and metastasis of lung adenocarcinoma by targeting RhoGDI1 and ALCAM.
Song Q; Xu Y; Yang C; Chen Z; Jia C; Chen J; Zhang Y; Lai P; Fan X; Zhou X; Lin J; Li M; Ma W; Luo S; Bai X
Cancer Res; 2014 Jun; 74(11):3031-42. PubMed ID: 24710410
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-197 induces epithelial-mesenchymal transition and invasion through the downregulation of HIPK2 in lung adenocarcinoma.
Zhang N; Tian L; Miao Z; Guo N
J Genet; 2018 Mar; 47(1):47-53. PubMed ID: 29666324
[TBL] [Abstract][Full Text] [Related]
15. miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma.
Yu M; Xue H; Wang Y; Shen Q; Jiang Q; Zhang X; Li K; Jia M; Jia J; Xu J; Tian Y
Int J Oncol; 2017 Mar; 50(3):975-983. PubMed ID: 28098858
[TBL] [Abstract][Full Text] [Related]
16. miR-24-3p/FGFR3 Signaling as a Novel Axis Is Involved in Epithelial-Mesenchymal Transition and Regulates Lung Adenocarcinoma Progression.
Jing P; Zhao N; Xie N; Ye M; Zhang Y; Zhang Z; Li M; Lai X; Zhang J; Gu Z
J Immunol Res; 2018; 2018():2834109. PubMed ID: 29850625
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-451 induces epithelial-mesenchymal transition in docetaxel-resistant lung adenocarcinoma cells by targeting proto-oncogene c-Myc.
Chen D; Huang J; Zhang K; Pan B; Chen J; De W; Wang R; Chen L
Eur J Cancer; 2014 Nov; 50(17):3050-67. PubMed ID: 25310895
[TBL] [Abstract][Full Text] [Related]
18. Expression of flotillin-2 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.
Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Wang ZM
Int J Clin Exp Pathol; 2015; 8(1):601-7. PubMed ID: 25755751
[TBL] [Abstract][Full Text] [Related]
19. miR-218 suppresses epithelial-to-mesenchymal transition by targeting Robo1 and Ecop in lung adenocarcinoma cells.
Li YJ; Zhang W; Xia H; Zhang BS; Chen P; Zhao YL; Li J
Future Oncol; 2017 Dec; 13(28):2571-2582. PubMed ID: 28936884
[TBL] [Abstract][Full Text] [Related]
20. MiR-138 inhibits cell proliferation and reverses epithelial-mesenchymal transition in non-small cell lung cancer cells by targeting GIT1 and SEMA4C.
Li J; Wang Q; Wen R; Liang J; Zhong X; Yang W; Su D; Tang J
J Cell Mol Med; 2015 Dec; 19(12):2793-805. PubMed ID: 26283050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
